全球医用推进剂市场

预计到 2030 年全球医用推进剂市场规模将达 4.834 亿美元

全球医用推进剂市场规模预计在2024年为2.887亿美元，到2030年将达到4.834亿美元，在2024-2030年的分析期间内，复合年增长率为9.0%。本报告分析的细分市场之一HFA 134A预计复合年增长率为9.6%，到分析期结束时规模将达到2.665亿美元。 HFA 227EA细分市场在分析期间的复合年增长率预计为7.6%。

美国市场规模估计为 7,860 万美元，中国市场预计复合年增长率为 13.8%

美国医用推进剂市场规模预计2024年达到7,860万美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.052亿美元，在2024-2030年的分析期间内，复合年增长率为13.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.9%和8.2%。在欧洲，预计德国市场的复合年增长率约为6.4%。

全球医用推进剂市场－主要趋势与驱动因素摘要

医用推进剂如何实现拯救生命的治疗？

医用推进剂在呼吸系统药物的输送中起着至关重要的作用，尤其是透过定量吸入器 (MDI) 输送，这使得它们对于治疗气喘、慢性阻塞性肺病(COPD) 和其他肺部疾病等慢性疾病至关重要。这些物质能够将雾化药物有效地直接输送到肺部，使患者能够快速获得精确的剂量和药效。与干粉吸入器不同，以推进剂为基础的 MDI 对儿童、老年人和严重病人特别有益，因为他们可能缺乏操作呼吸驱动装置的吸气力量。全球 MDI 的广泛使用维持了对医用级推进剂的持续需求，这类推进剂需要高纯度、无毒和稳定。最新一代推进剂，例如氢氟烷 (HFA)，根据针对臭氧消耗物质的环境法规取代了氯氟烃 (CFC)。氢氟烷烃 (HFA) 因其安全性、不可燃性以及与多种活性药物成分的兼容性而广受认可。医用推进剂不仅必须确保精准的药物输送，还必须在长期储存过程中保持配方稳定性和设备性能。均匀稳定地分散细颗粒的能力是有效吸入疗法的关键。随着全球呼吸健康需求的持续增长，医用推进剂在输送救命治疗药物方面发挥的关键作用，正在强化其作为全球药物输送系统基本要素的作用。

环境问题和监管压力如何改变医疗推进剂市场？

随着人们环保意识的增强和全球法规结构的加强，医药推进剂产业正经历重大变革时期。从历史上看，基于氟氯化碳的推进剂曾广泛用于吸入器，直到人们认识到它们的臭氧消耗效应，并透过《蒙特娄议定书》等协议实施国际禁令。这为氢氟烷的开发和应用铺平了道路，氢氟烷对臭氧层无害，但具有相对较高的全球暖化潜势值 (GWP)。因此，该行业目前正在寻求低 GWP 的 HFA 替代品，以提供相同的治疗益处，而不会显着导致气候变迁。人们正在研究氢氟烯烃 (HFO) 等推进剂，因为它们在保持药物输送所需性能特征的同时，可显着降低 GWP 并具有环保特性。美国环保署和欧洲药品管理局等监管机构正在透过政策指导和环境影响评估鼓励製药公司向更环保的推进剂过渡。製造商正在投资配方研究、设备相容性测试和毒性研究，以确保新型推进剂符合严格的安全性和有效性标准。这种转变不仅关乎技术，也关乎经济效益。挑战在于如何在环境目标与患者可近性、可负担性和治疗可靠性之间取得平衡。随着永续性成为医疗保健领域的关键标准，医用推进剂向更绿色解决方案的演变势在必行，对呼吸照护的未来至关重要。

临床应用和设备相容性如何影响推进剂的选择？

医用推进剂的选择在很大程度上取决于预期的临床应用及其与药物製剂和输送装置的兼容性。特别是，用于治疗呼吸系统疾病的吸入器依赖推进剂的特定物理化学性质，以确保药物均匀分散和精准给药。合适的推进剂必须能够溶解或悬浮活性药物成分，而不会降解或改变药物动力学。它还必须是惰性的，对呼吸道无刺激性，并且不含可能影响患者安全或监管核准的污染物。除了化学相容性之外，机械方面的考量也至关重要。推进剂必须与MDI装置中使用的致动器、计量阀和容器有效配合，以确保一致的喷雾模式和粒径分布。这些特性直接影响药物在肺部的沉积，最终影响治疗的临床疗效。含有多种活性成分的联合治疗使配方更加复杂，需要仔细校准推进剂在压力和长期条件下的行为。新兴药物类别和生技药品也带来了新的配方挑战，影响着推进剂的开发。在兽医学中，呼吸系统药物也透过雾化途径输送，因此推进剂的兼容性仍然至关重要。此外，随着远端医疗和居家医疗服务的发展，依赖可靠推进剂的便携式、易于使用的吸入装置也变得越来越重要。所有这些因素共同确保了医用推进剂的选择并非随意，而是深植于配方科学和药物输送系统的力学原理。

推动全球医用推进剂市场扩张的因素有哪些？

医用推进剂市场的成长受到呼吸系统疾病盛行率上升、技术进步、监管变化和环境创新等多种因素的共同推动。首先，全球气喘、慢性阻塞性肺病和过敏症盛行率的上升推动了对依赖推进剂有效输送的吸入疗法的需求。其次，气雾剂科学和定量吸入器技术的进步正在扩大可供吸入的药物范围，从而扩大了推进剂市场。第三，老化和都市化等人口结构变化导致呼吸系统疾病负担加重，特别是在空气污染导致健康恶化的中低收入国家。第四，正在进行的製药研发投资正在将现有药物改造成可吸入形式，从而增加了对相容高效推进剂的需求。第五，监管部门不再关注高 GWP 物质，这推动了环境永续推进剂的创新，创造了一个专注于绿色化学和环境相容材料的新市场领域。第六，家庭医疗保健的扩展以及对便携式、易用治疗设备的需求，推动了依赖可靠推进剂的微型吸入器系统的使用。第七，消费者对空气品质和预防保健意识的不断增强，鼓励对呼吸系统疾病进行早期诊断和持续治疗，从而推动了吸入器类药物处方的增加。最后，製药公司和设备製造商之间日益加强的合作，使得能够共同开发既能优化治疗效果又能优化环境永续性的药物-设备组合。这些因素共同创造了一个充满活力且不断发展的市场环境，其中，「工业废水」这个关键字依然存在，成为全球呼吸健康解决方案中一个经常被忽视但至关重要的组成部分。

部分

类型（HFA 134A、HFA 227EA、HFA-152A）、用途（按压式定量吸入器、呼吸定量吸入器）、最终用途（医疗设备公司、契约製造组织、研究机构）

受访公司范例

• Aeropres Corporation
• Arkema SA
• Avanti Polar Lipids（Croda）
• BOC Healthcare（Linde Group）
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor（Orbia Advance Corp.）
• MPI Research（Charles River）
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay SA
• SRF Limited
• Tazzetti SpA
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Medical Propellants Market to Reach US$483.4 Million by 2030

The global market for Medical Propellants estimated at US$288.7 Million in the year 2024, is expected to reach US$483.4 Million by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. HFA 134A, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$266.5 Million by the end of the analysis period. Growth in the HFA 227EA segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$78.6 Million While China is Forecast to Grow at 13.8% CAGR

The Medical Propellants market in the U.S. is estimated at US$78.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Medical Propellants Market - Key Trends & Drivers Summarized

How Are Medical Propellants Enabling the Delivery of Life-Saving Therapies?

Medical propellants play a crucial role in the administration of respiratory drugs, particularly through metered-dose inhalers (MDIs), making them indispensable in treating chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These substances serve as the driving force behind the effective delivery of aerosolized medication directly into the lungs, allowing patients to receive precise dosages with rapid onset of action. Unlike dry powder inhalers, MDIs using propellants are especially beneficial for pediatric, elderly, and critically ill patients who may lack the inspiratory strength to operate breath-actuated devices. The widespread reliance on MDIs globally has sustained consistent demand for medical-grade propellants, which are required to be highly pure, non-toxic, and stable. The current generation of propellants, such as hydrofluoroalkanes (HFAs), replaced chlorofluorocarbons (CFCs) following environmental regulations targeting ozone-depleting substances. HFAs are widely recognized for their safety, non-flammability, and compatibility with a variety of active pharmaceutical ingredients. Medical propellants must not only ensure accurate drug delivery but also maintain formulation stability and device performance over prolonged storage. Their ability to disperse fine particles evenly and consistently is a cornerstone of effective inhalation therapy. As global respiratory health needs continue to rise, the essential function of medical propellants in delivering life-saving therapies reinforces their role as a fundamental element in drug delivery systems worldwide.

How Are Environmental Concerns and Regulatory Pressures Reshaping the Medical Propellants Market?

The medical propellants industry is undergoing significant transformation in response to growing environmental awareness and tightening global regulatory frameworks. Historically, chlorofluorocarbon-based propellants were widely used in inhalers until the realization of their ozone-depleting effects led to international bans under agreements such as the Montreal Protocol. This paved the way for the development and adoption of hydrofluoroalkanes, which do not harm the ozone layer but still carry a relatively high global warming potential (GWP). As a result, the industry is now exploring low-GWP alternatives to HFAs that can offer the same therapeutic efficacy without contributing substantially to climate change. Propellants such as hydrofluoroolefins (HFOs) are being investigated for their environmentally friendly profile, offering significantly reduced GWP while maintaining performance characteristics required for drug delivery. Regulatory bodies including the U.S. Environmental Protection Agency and the European Medicines Agency are encouraging pharmaceutical companies to transition to greener propellants through policy guidance and environmental impact assessments. Manufacturers are investing in reformulation research, device compatibility testing, and toxicity studies to ensure that new propellants meet stringent safety and efficacy standards. These shifts are not only technical but also economic, as companies must adapt their production facilities and supply chains to accommodate alternative substances. The challenge lies in balancing environmental goals with patient access, affordability, and therapeutic reliability. As sustainability becomes a key criterion in healthcare, the evolution of medical propellants toward greener solutions is both inevitable and pivotal for the future of respiratory care.

How Do Clinical Applications and Device Compatibility Influence Propellant Selection?

The selection of medical propellants is heavily influenced by the intended clinical applications and the compatibility of the propellant with drug formulations and delivery devices. Most notably, inhalers used in the treatment of respiratory diseases rely on specific physicochemical properties of propellants to ensure uniform drug dispersion and accurate dosing. A suitable propellant must be able to dissolve or suspend active pharmaceutical ingredients without causing degradation or changes in pharmacokinetics. It must also be inert, non-irritating to the respiratory tract, and free from contaminants that could impact patient safety or regulatory approval. In addition to chemical compatibility, mechanical considerations are paramount. The propellant must work effectively with the actuator, metering valve, and container used in the MDI device to ensure consistent spray pattern and particle size distribution. These characteristics directly impact the deposition of the drug in the lungs and, therefore, the clinical effectiveness of the therapy. For combination therapies involving multiple active ingredients, the formulation becomes even more complex, requiring careful calibration of propellant behavior under pressure and over time. Emerging drug classes and biologics also pose new formulation challenges that influence propellant development. In veterinary medicine, where respiratory therapies are also delivered through aerosolized routes, propellant compatibility remains critical. Furthermore, as telehealth and home care services grow, portable and user-friendly inhalation devices relying on dependable propellants are becoming increasingly important. All these factors combined ensure that the choice of a medical propellant is not arbitrary but deeply embedded in both the science of formulation and the mechanics of drug delivery systems.

What Factors Are Driving the Expansion of the Global Medical Propellants Market?

The growth in the medical propellants market is driven by a combination of rising respiratory disease prevalence, technological advancement, regulatory change, and environmental innovation. First, the increasing global incidence of asthma, COPD, and allergies is creating greater demand for inhalation therapies that rely on propellants for effective delivery. Second, advances in aerosol science and metered-dose inhaler technologies are expanding the scope of medications that can be administered via inhalation, leading to a broader market for propellants. Third, demographic changes such as aging populations and urbanization are contributing to a higher burden of respiratory illnesses, particularly in low- and middle-income countries where air pollution exacerbates health conditions. Fourth, ongoing pharmaceutical R&D investments are leading to the reformulation of existing drugs into inhalable forms, thereby increasing the need for compatible and efficient propellants. Fifth, regulatory shifts away from high-GWP substances are prompting innovation in environmentally sustainable propellants, creating new market segments focused on green chemistry and eco-compliant materials. Sixth, the expansion of home healthcare and the demand for portable, user-friendly therapeutic devices are boosting the use of compact inhaler systems that depend on reliable propellants. Seventh, heightened consumer awareness of air quality and preventive care is encouraging earlier diagnosis and consistent treatment of respiratory conditions, which in turn drives prescription volume for inhaler-based medications. Lastly, increased collaboration between pharmaceutical companies and device manufacturers is enabling the co-development of drug-device combinations that optimize both therapeutic outcomes and environmental sustainability. These combined factors are shaping a dynamic and evolving market landscape in which medical propellants remain a critical, though often overlooked, component of global respiratory health solutions.

SCOPE OF STUDY:

The report analyzes the Medical Propellants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HFA 134A, HFA 227EA, HFA-152A); Application (Press Metered Dose Inhalers Application, Breath Actuated Metered Dose Inhalers Application); End-Use (Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use, Research Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Aeropres Corporation
• Arkema S.A.
• Avanti Polar Lipids (Croda)
• BOC Healthcare (Linde Group)
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor (Orbia Advance Corp.)
• MPI Research (Charles River)
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay S.A.
• SRF Limited
• Tazzetti S.p.A.
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Medical Propellants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Environmental Regulations and Phase-Out of High-GWP HFCs Throw the Spotlight on Next-Generation Low-Impact Medical Propellants
  • Rising Global Burden of Respiratory Diseases Propels Growth in Demand for Propellant-Based Inhalation Therapies
  • Shift Toward Patient-Friendly Drug Delivery Systems Expands the Addressable Market Opportunity for Pressurized MDIs
  • Approvals of New HFA Alternatives Strengthen the Business Case for Sustainable Medical Propellant Transitions
  • Inhaler Innovation for COPD and Asthma Management Accelerates Adoption of Optimized Propellant Formulations
  • Global Push to Meet Kigali Amendment Targets Spurs Urgency in Developing Eco-Conscious Medical Propellant Pipelines
  • Demand for Dose Consistency and Stability Generates Opportunities for Reformulated Propellant-Drug Combinations
  • Manufacturing Scale-Up for New Propellants Throws the Spotlight on Supply Chain Readiness and Fill-Finish Capabilities
  • Respiratory Therapy Access in Emerging Markets Sustains Growth of HFA-Based Propellants in Cost-Sensitive Regions
  • Digital Inhalers and Smart Devices Drive Innovation in Propellant Compatibility and Integration
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Medical Propellants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for HFA 134A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for HFA 227EA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for HFA-152A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Press Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Breath Actuated Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION